
Ben Robbins
General Partner
GP at GV, specializing in investments in healthcare delivery and neuropsychiatric therapeutics. As a psychiatrist by training, he leads GV's investments in mental health-related startups like Headway and Brightline. Other investments include Aspire, Rodin, and Waltz Health.
Investor scope
Investment criteria breakdown.
Investment stages
Seed
Series A
Series B+
Target regions
USA
Canada
Europe
Investment ranges
$500K - $1M
$1M - $3M
$3M - $10M
$10M - $50M
Focus areas
Enterprise
Consumer
Biotech
Deeptech
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.